Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389155
Status:
COMPLETED
Last Update Posted:
2015-12-07
First Post:
2006-10-17
Brief Title:
First-Line Treatment of Advanced Bladder Cancer Randomized vs Gemcitabine Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bladder Cancer |
| Transitional Cell Carcinoma |
| Metastasis |
Keywords:
| Name | View |
|---|---|
| Advanced or metastatic transitional cell carcinoma of the urothelium | View |